opportunistic infections

An Exploratory Analysis of HIV Treatment Research and Development Investments in 2009

Published by: 
UNAIDS

This report is a preliminary assessment of global investments in research and development
(R&D) devoted to the discovery and development of new therapies and treatment strategies
for HIV. As part of a broader effort to track and analyze HIV/AIDS spending, UNAIDS
commissioned the Treatment Action Group (TAG) and AVAC to measure global R&D spending
for HIV treatment, starting with the year 2009.
From a total of 144 surveyed institutions, 48 funders reported investing $2.5 billion in HIV
treatment R&D in 2009. The scope of HIV treatment R&D included HIV basic science, drug
discovery, drug development, diagnostics, and operational and implementation science on

The Integration of HIV/AIDS Care and Support into Primary Health Care in Gauteng Province

Published by: 
Health Systems Trust
This study aimed to assess the integration of HIV/AIDS care and support in Gautengs primary health care (PHC) services. With this aim in mind, the research sought to provide answers to three main sets of questions. Firstly, are care and support services for people with HIV/AIDS being provided at PHC clinics, what is the quality of these services, and to what extent are these services being utilised? Secondly, are the inputs (e.g. staff knowledge and attitudes) and support systems (e.g. drug supplies), necessary for good quality, accessible HIV/AIDS care, present in the PHC infrastructure? Thirdly, what if any, systems changes are required to improve the access and quality of PHC services for people living with HIV/AIDS? This research was conducted in collaboration with, and partly funded by, the Gauteng Provincial Department of Health which is in the process of disseminating primary health care clinical guidelines in the Province.